| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.27B | 13.52B | 13.08B | 12.22B | 12.17B | 11.58B |
| Gross Profit | 3.01B | 4.11B | 4.42B | 3.78B | 3.53B | 3.57B |
| EBITDA | 2.25B | 3.06B | 3.32B | 2.85B | 2.74B | 2.65B |
| Net Income | 1.17B | 1.29B | 1.75B | 1.29B | 1.28B | 1.25B |
Balance Sheet | ||||||
| Total Assets | 14.12B | 14.52B | 14.88B | 14.36B | 13.72B | 12.96B |
| Cash, Cash Equivalents and Short-Term Investments | 5.09B | 2.97B | 5.16B | 5.51B | 5.65B | 5.99B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.95B | 1.41B | 1.79B | 1.85B | 1.76B | 1.68B |
| Stockholders Equity | 12.17B | 13.11B | 13.09B | 12.51B | 11.96B | 11.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.03B | 2.21B | 1.72B | 702.00M | 281.00M |
| Operating Cash Flow | 0.00 | 1.91B | 2.46B | 2.47B | 1.36B | 1.43B |
| Investing Cash Flow | 0.00 | -2.24B | -563.00M | -1.77B | -1.09B | -1.12B |
| Financing Cash Flow | 0.00 | -1.36B | -1.25B | -836.00M | -615.00M | -558.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥549.22B | 17.93 | 15.67% | 1.31% | 9.02% | 21.15% | |
73 Outperform | ¥16.89B | 13.03 | ― | 3.53% | 3.36% | -23.56% | |
73 Outperform | ¥50.07B | 13.96 | ― | 2.63% | 8.01% | 29.66% | |
73 Outperform | ¥10.79T | 18.28 | ― | 3.99% | 7.55% | 3.27% | |
63 Neutral | ¥20.35B | 27.91 | ― | ― | 25.92% | -10.55% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
56 Neutral | ¥10.52T | 14.83 | 13.75% | 2.85% | 4.05% | 13.53% |